Dr. Kurian Abraham, M.D.

Specializes in Psychiatry and Neurology. Dr. Abraham is a Diplomate of the American Board of Psychiatry and Neurology (ABPN). Abraham is a researcher in Alzheimer’s disease and other central nervous system disorders. Dr. Abraham has a Duke/GlaxoSmithKline psychopharmacology research fellowship. He has over 16 years of clinical trial experience and has contributed to the clinical trials for all current medication available in the market for Alzheimer’s disease. Our research site was selected as the only site from North Carolina to be involved in a pivotal study for Alzheimer’s disease sponsored by a major pharmaceutical company. In addition, Dr. Abraham is a Principal Investigator with NHCR and is a co-founder of New Hope Specialty Clinic. Dr. Abraham is a member of the Syneos SAG group to provide expertise in drug development and protocol review.